眼科新进展
眼科新進展
안과신진전
RECENT ADVANCES IN OPHTHALMOLOGY
2001年
3期
187-188
,共2页
许泽广%王弘光%王芹%周瑞雅%王超廷
許澤廣%王弘光%王芹%週瑞雅%王超廷
허택엄%왕홍광%왕근%주서아%왕초정
新生血管性青光眼%青光眼阀
新生血管性青光眼%青光眼閥
신생혈관성청광안%청광안벌
neovascular glaucoma%glaucoma value
目的评价Ahemd青光眼阀植入术治疗有视功能的新生血管性青光眼的疗效及安全性。方法对26例26眼有视功能的新生血管性青光眼施行颞上象限到赤道部区域的Ahemd青光眼阀植入术。结果术后经4~26mo(平均8mo)的随访观察,22例视力提高或不变,占86.4%,无1例因手术而失明;17眼眼压控制在0.8~2.8 kPa,眼压控制率为65.4%.术后并发症包括:短暂性前房出血,术后早期低眼压,引流管口阻塞及植入盘脱出。结论 Ahemd青光眼阀植入术治疗有视功能的新生血管性青光眼是一种有效且安全的方法。
目的評價Ahemd青光眼閥植入術治療有視功能的新生血管性青光眼的療效及安全性。方法對26例26眼有視功能的新生血管性青光眼施行顳上象限到赤道部區域的Ahemd青光眼閥植入術。結果術後經4~26mo(平均8mo)的隨訪觀察,22例視力提高或不變,佔86.4%,無1例因手術而失明;17眼眼壓控製在0.8~2.8 kPa,眼壓控製率為65.4%.術後併髮癥包括:短暫性前房齣血,術後早期低眼壓,引流管口阻塞及植入盤脫齣。結論 Ahemd青光眼閥植入術治療有視功能的新生血管性青光眼是一種有效且安全的方法。
목적평개Ahemd청광안벌식입술치료유시공능적신생혈관성청광안적료효급안전성。방법대26례26안유시공능적신생혈관성청광안시행섭상상한도적도부구역적Ahemd청광안벌식입술。결과술후경4~26mo(평균8mo)적수방관찰,22례시력제고혹불변,점86.4%,무1례인수술이실명;17안안압공제재0.8~2.8 kPa,안압공제솔위65.4%.술후병발증포괄:단잠성전방출혈,술후조기저안압,인류관구조새급식입반탈출。결론 Ahemd청광안벌식입술치료유시공능적신생혈관성청광안시일충유효차안전적방법。
Objective To investigate the efficacy and security of the treatment for the with visual function in neovascular glaucoma with Ahmed glaucoma value(AGV ).Methods Twenty-six cases (26 eyes) with visual function in neovascular glaucoma underwent AGV implantation. Results After surgery,the follow-up periods lasted for 4 to 26 months (mean 8 months ),the visual acuity of 22 eyes (86.4%) was improved or remained the same,no case of the blindness was found. The mean intraocular pressure was between 0.8~2.8kPa in 17 eyes,and the Yate of control reaches to 65.4% , the postoperative complication included transicent hyphema, Early hypotony, obstruction of the tube tip and drop out of the plate.Conclusion The AGV implantation treating those with visual function in neovascular glaucoma is an effective and safe method.